3rd Annual BioPharma Asia Congress 2014

Topics

• Managing the role of innovator companies and commercialising biosimilars
• Strategies for gaining access to emerging markets
• Case studies of the challenges and opportunities in clinical trials including patient safety and pharmacovigilence, insights into developing an efficient scale up process, demonstrating CMC and biosimilarity considerations
• Manufacturing biosimilars, single use systems, achieving quality by design and innovative production platforms

Who should Attend

Senior level attendees from leading biopharmaceutical, pharmaceutical, diagnostics, biotechnology, government, academics, solution provider companies and CRO involved in Antibody Engineering, Antibody Drug Conjugates, Bioinformatics, Antibody Expression, Biopharmaceuticals, Biological research, Biosimilars, BioProcessing, Cell line engineering and Biologic development, Cell culture manufacturing, Fermentation, Downstream Processing, Manufacturing, Immunogenicity, Operation, Microarray, Process development, Outsourcing, Protein Aggregation, Process Sciences, Protein Expression, Protein Engineering, Protein Science, Protein Production, Quality Validation, Purification, Structural Biology, Screening, Therapeutics Proteins, Tech Transfer and Upstream Processing.